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INTRODUCTION
It is now generally accepted that the workplace environment 
can lead to the development of different types of work-related 
asthma, including occupational asthma (OA) (i.e., asthma 
caused being at work) and work-exacerbated asthma (i.e., pre-
existing or coincident asthma exacerbated by non-specific stim-
uli at work).
1,2 OA may result from either immunologically-me-
diated sensitization to occupational agents (i.e., ‘allergic’ occu-
pational asthma or ‘occupational asthma with a latency peri-
od’) or from exposure(s) to high concentrations of irritant com-
pounds (i.e., ‘irritant-induced asthma’), which is best typified 
by ‘reactive airways dysfunction syndrome’ .
1,2 In recent years, 
there has been a growing recognition that work-related asthma 
represents a significant public health concern because of its high 
prevalence (~15% of adult asthma)
3 and substantial health and 
socio-economic impacts.
4 OA is potentially preventable, by ef-
fective control of respiratory sensitizers in the workplace. Ac-
cordingly, identifying causal agents and associated risk factors 
is a key step towards optimal prevention of the disease. This re-
view aims at summarizing our current understanding of the 
factors that determine the inception of ‘allergic’ OA.
Occupational Asthma: Etiologies and Risk Factors
Olivier Vandenplas*
Department of Chest Medicine, Mont-Godinne Hospital, Université Catholique de Louvain, Yvoir, Belgium
ETIOLOGICAL AGENTS
Workplace agents that are known to cause allergic OA include 
high-molecular-weight (HMW) (glyco)-proteins from vegetal 
and animal origins and low-molecular-weight (LMW) com-
pounds. HMW proteins and a few LMW compounds (e.g., plat-
inum salts, reactive dyes, acid anhydrides, sulfonechloramide, 
and some wood species) act through a documented IgE-medi-
ated mechanism.
5,6 The immunological mechanisms underly-
ing the effects of most LMW agents (e.g., isocyanates, persul-
phate salts, aldehydes, and wood dusts) have not been fully 
characterized.
Sensitizing potential
Identifying characteristics associated with the induction of 
airway sensitization is fundamental to the implementation of 
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The purpose of this article is to critically review the available evidence pertaining to occupational, environmental, and individual factors that can af-
fect the development of occupational asthma (OA). Increasing evidence suggests that exploration of the intrinsic characteristics of OA-causing agents 
and associated structure-activity relationships offers promising avenues for quantifying the sensitizing potential of agents that are introduced in the 
workplace. The intensity of exposure to sensitizing agents has been identified as the most important environmental risk factor for OA and should re-
main the cornerstone for primary prevention strategies. The role of other environmental co-factors (e.g., non-respiratory routes of exposure and con-
comitant exposure to cigarette smoke and other pollutants) remains to be further delineated. There is convincing evidence that atopy is an important 
individual risk factor for OA induced by high-molecular-weight agents. There is some evidence that genetic factors, such as leukocyte antigen class 
II alleles, are associated with an increased risk of OA; however, the role of genetic susceptibility factors is likely to be obscured by complex gene-en-
vironment interactions. OA, as well as asthma in general, is a complex disease that results from multiple interactions between environmental fac-
tors and host susceptibilities. Determining these interactions is a crucial step towards implementing optimal prevention policies.
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primary preventive strategies. Research performed over recent 
years has highlighted the possible role of inherent protease ac-
tivity, surface features, and glycosylation patterns of HMW al-
lergens in the initiation of Th2 and IgE antibody responses.
7 
There is growing evidence that allergens possess common mo-
lecular features that enable them to be recognized by innate 
immune defenses as Th2-inducing antigens. For example, re-
cent data suggest that allergens with lipid-binding properties, 
such as the major house dust mite allergen Der p2, have intrin-
sic adjuvant activity and can interact with the Toll-like receptor 
4 signaling pathway.
8 These events could be further amplified 
by proteolytically active allergens through the digestion of cell 
surface molecules involved in regulating innate and adaptive 
immune function, thereby favoring Th2 responses. These data 
support the observation that enzymes are a common cause of 
OA in a wide variety of occupations.
9 Resistance to degradation 
may also be important for some occupational HMW allergens, 
which may be altered by physical or chemical agents during in-
dustrial or manufacturing processes. This is best illustrated by 
the persistence of allergenic epitopes derived from the Hevea 
braziliensis tree in natural rubber latex, despite treatment with 
ammonia and vulcanization at high temperature.
In contrast to protein allergens, LMW agents are incomplete 
antigens (i.e., haptens) that must first bind to carrier macro-
molecules to become immunogenic. It has long been recog-
nized that OA-causing LMW agents are typically highly reactive 
electrophilic compounds that are capable of combining with 
the hydroxyl, amino, and thiol functionalities on airway pro-
teins.
6,10,11
LMW sensitizing agents also include transition metals salts, 
where the asthmagenic mechanism is thought to involve coor-
dination bonding with human proteins.
12 Quantitative struc-
ture-activity relationship (QSAR) models have been developed 
for the prospective identification of potentially sensitizing chem-
icals.
13 Comparisons of the chemical substructures present in 
LMW organic asthmagens and non-sensitizing chemicals have 
identified several reactive groups that are associated with a high 
risk of respiratory sensitization, such as isocyanate (N=C=O), 
carbonyl (C=O), and amine (NH2), particularly when two or 
more groups are present within the same molecule.
14 These 
multiple reactive groups could react simultaneously with differ-
ent amino acids present on native human proteins, leading to 
intra-molecular cross-linking, conformational changes, and the 
production of neo-epitopes within the protein molecules. Such 
neo-epitopes could be involved in the initiation of respiratory 
sensitization.
Causal agents
A large number of substances used in the workplace can lead 
to the development of allergic OA. Updated lists of causal agents 
and occupations are available on the web (e.g., http://www.
asthme.csst.qc.ca and http://www.asmanet.com). A quick 
search of PubMed through 2009 and a personal bibliography 
for articles published before 1976 identified about 360 com-
pounds or processes that have been described as causing OA, 
with a mean of 12 new causal agents reported annually since 
1990. However, data derived from voluntary notification pro-
grams and compensation statistics of OA in various countries 
show that only a few agents (flour, isocyanates, latex, persul-
phate salts, aldehydes, animals, wood dusts, metals, enzymes) 
account for 50-90% of reported cases (Table 1).
15-23 Neverthe-
less, the distribution of causal agents may vary across geo-
graphical areas, depending upon the pattern of industrial activ-
ities. For example, a high rate of OA due to metal machining 
fluids (11% of all cases), adhesives (7%), and chrome (7%) has 
been reported in the West Midlands, an area in the UK with 
Table 1. Principal agents shown to cause occupational asthma in various countries
Agent
Finland
*15 Canada,  
Quebec
*16 UK
†17 France
†18 South 
Africa
†19
Austra-
lia
†20
Bel-
gium
†21 Belgium
*‡
Spain, 
Catalo-
nia
†22
Korea
*†23
1989-
1994
1995-
2002
1990-
1994
1995-
1999
1992-
1995
1996-
2001
1996-
1999
1997-
1999
1997-
1999
2000-
2002
1993-
1997
1998-
2002
2002 1992-
2006
Flour, cereals 23% 17% 21% 24% 9% 9% 22% 12% 2% 13% 36% 31% 10% 1%
Isocyanates 6% 2% 30% 18% 14% 13% 14% 20% 6% 17% 24% 15% 16% 50%
Latex <1% <1% <1% 10% 1% 3% 7% 24% 3% 10% 11% 23% 7% 4%
Persulphates 1% 2% na na na na 6% na na 4% 1% 2% 12% na
Aldehydes 2% 1% na na 5% 4% 6% 1% 5% 1% 1% 1% 2% 3%
Animals 37% 24% 5% 5% 5% 5% 2% 1% 2% 4% 0% 1% 4% na
Wood dusts 4% 3% 8% 9% 4% 6% 4% na 14% 3% 9% 6% 8% 1%
Metals 1% 1% 8% 7% 5% 4% na 15% 7% 4% 4% 4% na 9%
Enzymes <1% <1% na na 1% 2% 3% na na 3% 6% 4% na na
na, data not available.
*Medico-legal statistics; 
†Voluntary notification programs; 
‡Unpublished data derived from the Belgian Workers’ Compensation Board.Occupational Asthma: Etiologies and Risk Factors
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high manufacturing activity.
24 In some countries, greenhouse 
cultivation is a growing activity that may lead to unusually high 
levels of exposure to airborne plant allergens that may induce 
occupational rhinitis and asthma in a substantial proportion of 
exposed workers.
25 Additionally, greenhouse workers may be-
come sensitized to pest insects, predatory mites used for the bi-
ological control of pests, molds, and latex gloves. In the south-
ern part of Korea, the Tetranychidae mite Panonychus citri has 
been identified as a common cause of IgE-mediated respirato-
ry allergies in citrus farmers.
26
There is currently little information on changes in the patterns 
of causal agents over time (Table 1).
15-17 The number of cases of 
isocyanate-induced OA appears to have declined in some coun-
tries,
16 likely due to the implementation of preventive measures. 
Available data also indicate that there has been a marked in-
crease in the number of reported OA cases due to latex use dur-
ing the 1990s. However, an analysis of the Belgian compensa-
tion data using the year of asthma onset, rather than the year of 
claim submission, showed that the incidence of latex-induced 
asthma decreased in the late 1990s, together with a sharp decline 
in the use of powdered latex gloves.
27 Over the period from 1998 
to 2002, the Finnish Register of Occupational Diseases docu-
mented a substantial increase in the rate of OA caused by sensi-
tization to molds in white-collar workers employed in water-
damaged buildings. This population accounted for up to 18% of 
notified cases in 1998-2002.
15 During the same period, there 
was a downward trend in OA caused by cow dander, which re-
sulted from a marked decrease in agricultural activities and 
changes in dairy farming practices.
At-risk occupations
Notification programs have generally reported the highest in-
cidence rates of OA in bakers and pastry makers, other food 
processors, spray painters, hairdressers, wood workers, health-
care workers, cleaners, farmers, laboratory technicians, and 
welders.
17,18,21 In fact, these occupations accounted for about 
two-thirds of all notified cases of OA, which may be relevant for 
targeting prevention and surveillance programs. In recent years, 
population-based studies conducted in various countries world-
wide have consistently found that cleaning activities were asso-
ciated with an excess risk of asthma, compared with unexposed 
individuals.
28,29 Additionally, the Third National Health and Nu-
trition Examination Survey (NHANES III; 1988-1994) showed 
that cleaners were at an increased risk of experiencing work-re-
lated asthma symptoms (odds ratio [OR]: 2.4; 95% confidence 
interval [CI]: 0.5-10.6) and work-related wheezing (OR: 5.4; 95% 
CI: 2.4-12.2).
30 Industrial and domestic cleaners use a wide va-
riety of products containing irritant chemicals (e.g., detergents, 
acids, alkali, solvents, chelating compounds), as well as some 
potentially sensitizing substances, including biocides (e.g., chlo-
ramine-T, aldehydes, quaternary ammonium derivatives), eth-
anolamines, enzymes, and latex gloves. Additionally, cleaners 
are exposed to various workplace and domestic pollutants and 
allergens, such as endotoxins, house dust mites, pets, and molds. 
Different agents and mechanisms are presumably involved in 
the development of cleaning-related asthma and rhinitis. Re-
cent studies found that a higher risk of asthma attacks
31 and 
new-onset asthma
32 was associated with exposure to bleach, 
ammonia, degreasing sprays, and accidental inhalation of va-
pors and gases from cleaning agents. These findings support an 
important role for acute and chronic exposure to irritants in in-
ducing ‘irritant-induced asthma’ (e.g., ‘reactive airways dys-
function syndrome’) and ‘work-exacerbated asthma.’ Data col-
lected by the Sentinel Event Notification System for Occupation-
al Risks (SENSOR) in four US states from 1993 to 1997 showed 
that 12% of the reported cases of work-related asthma were as-
sociated with exposure to cleaning products.
33 Among these 
cases, 20% were categorized as ‘work-exacerbated asthma’ and 
80% as new-onset asthma, including 22% with probable ‘reac-
tive airways dysfunction syndrome’ and the remainder with OA; 
however, the sensitizing agent was identified in only 14% of OA 
cases.
ENVIRONMENTAL RISK FACTORS
Environmental factors that are potentially involved in the ini-
tiation of OA include the level of exposure to sensitizing agents, 
the mode and route of exposure to these agents, and concomi-
tant exposure to pollutants at the workplace.
Level of exposure
The assessment of dose-response relationships in OA has 
been greatly enhanced by the development of immunoassay 
techniques for the measurement of low concentrations of air-
borne HMW allergens in the workplace, the use of personal 
sampling techniques, and the implementation of prospective 
cohort studies.
34 These studies have provided strong evidence 
supporting a dose-response relationship between the exposure 
level to occupational agents and the development of IgE-medi-
ated sensitization and work-related respiratory symptoms for 
agents acting through an IgE-mediated mechanism (e.g., wheat 
flour, fungal alpha-amylase, laboratory animal proteins, deter-
gent enzymes, snow crab allergens, platinum salts, acid anhy-
drides). An exposure-response gradient has been documented 
between the time-weighted average concentrations of isocya-
nates and the development of OA in a case-referent study.
35 In a 
recent survey of spray painters, a log-linear relationship was 
found between the presence of specific IgE antibodies against 
isocyanate oligomers and the level of exposure and work-relat-
ed symptoms.
36 Specific IgG levels appeared to be merely an in-
dicator of exposure.
The determination of dose-response relationships may have a 
major effect on establishing permissible concentrations for pre-
vention.
37 However, uncertainties remain with respect to the Vandenplas
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relative importance of peak versus average levels of exposure, 
the risk of sensitization at low concentrations (i.e., the ‘no-effect 
level’), and the shape of the dose-response curve.
38 There is some 
evidence among laboratory animal workers that high-level ex-
posures to laboratory animal allergens have a protective effect 
on the development of IgE-mediated sensitization and allergy 
symptoms.
39,40 These studies observed that a high level of expo-
sure to rat and mouse allergens was associated with increased 
levels of specific IgG4 antibodies, higher ratios of specific IgG4/
IgE antibodies, and a reduction in work-related symptoms. A 
large workforce cross-sectional study of bakery workers con-
ducted in the Netherlands also documented a bell-shaped ex-
posure-response relationship, especially for cumulative wheat 
allergen exposure with IgE sensitization, allergic respiratory 
symptoms, and asthma; however, the healthy worker effect 
(HWE) may have been a possible explanation for the bell-shaped 
relationship.
41 These findings are suggestive of a high-dose im-
munological tolerance to allergens associated with a modified 
Th2 cell response, which has been described for cat allergens in 
children.
42 However, the attenuation of sensitization at high-dose 
exposure levels has not been documented for other workplace 
allergens, such as flour and detergent enzymes, or even in oth-
er surveys of workers exposed to laboratory animals.
43 The 
mechanisms through which certain allergens induce tolerance 
at high exposure levels, while others drive a linear exposure–re-
sponse relationship remain unknown. The functional role of 
IgG4 antibodies in the protection of sensitization at high aller-
gen exposure levels has not been formally demonstrated. On 
the other hand, a recent survey of Korean bakery workers sug-
gests that wheat-specific IgG4 antibodies may play a role in the 
development of respiratory symptoms in exposed workers who 
lack wheat-specific IgE antibodies.
44
The interpretation of exposure-response relationships may be 
further complicated by the discordance between reported re-
spiratory symptoms and documented IgE-mediated sensitiza-
tion to occupational allergens.
45 For example, among Korean 
bakers, only a low proportion (25%) of symptomatic workers 
showed positive wheat-specific IgE antibodies.
44 Additionally, 
individual susceptibility factors may affect the exposure-re-
sponse relationships. Genetic markers could also be stronger 
determinants of sensitization to occupational agents at low lev-
els of exposure to occupational agents.
46 However, in the cohort 
of Dutch bakers mentioned above, associations between expo-
sure levels and the prevalence of sensitization to wheat aller-
gens and clinical outcomes were found only in atopic individu-
als.
41 The timing of exposure may also play a role because the 
onset of work-related asthma symptoms is consistently higher 
within the early period of exposure to the occupational agents.
47-49 
Exposure-response gradients are more clearly documented in 
those workers who develop these outcomes soon after the on-
set of exposure.
48 These findings indicate that the level of expo-
sure at critical time points may be more relevant to the devel-
opment of OA than cumulative doses of exposure or current 
levels of exposure at the time of investigation.
Mode of exposure
Differences in the mode of exposure to the same HMW agent 
may result in different patterns of IgE responses. In asthma epi-
demics caused by soybean dust released during soybean un-
loading into harbor silos, citizens became sensitized to Gly m 1 
and Gly m 2, which are proteins with a low molecular weight 
(7-8 kDa) that are concentrated in the hull. In contrast, bakers 
are predominantly sensitized to allergens with a higher molec-
ular weight that are present in both the soybean hull and flour.
50 
It has also been reported that workers may develop specific air-
way reactivity directed against one, but not the other forms of 
LMW chemicals (e.g., vapors of isocyanate monomers versus 
aerosols of isocyanates prepolymers; formaldehyde resin dust 
versus gaseous formaldehyde).
51,52 The extent to which the phys-
icochemical properties of LMW agents, such as volatility and 
solubility, may influence the patterns of airway deposition and 
the potential for inducing airway sensitization has not been ex-
tensively investigated. Recent experiments have shown that 
that the biophysics of exposure may have a strong influence on 
the formation of human protein conjugates with diisocyanates, 
which might affect the immunogenicity of the resulting conju-
gate.
53,54
Animal experiments have consistently demonstrated that der-
mal exposure to LMW occupational agents can initiate IgE-me-
diated respiratory sensitization with a predominant Th2-like 
immune response, as well as the development of eosinophilic 
airway inflammation and airway hyperresponsiveness to these 
agents.
55-57 The identification of type 1 keratins conjugated to 
hexamethylene diisocyanate after both skin and inhalation ex-
posure offers potentially new insights into the link between skin 
sensitization to LMW chemicals and the induction of airway 
hyperresponsiveness to isocyanates in animal models.
10 Much 
less is known regarding the potential impact of skin exposure 
on the initiation of OA in humans because the effects of dermal 
contact cannot readily be quantified or differentiated from those 
of inhalation exposure, as both occur simultaneously. Indirect 
evidence from a growing number of clinical and epidemiologi-
cal studies in workplaces where measured airborne exposures 
to isocyanates were very low or non-detectable suggests that 
skin exposure to these reactive chemicals can contribute to an 
increase in the risk for sensitization and asthma.
58
Co-exposure to pollutants
There is growing evidence that environmental pollutants, such 
as ozone, nitrogen dioxide, tobacco smoke, diesel exhaust par-
ticles, and endotoxin can act as adjuvants in allergic responses 
to common inhalant allergens.
59 However, there is limited in-
formation on the potential interactions between pollutants and 
sensitizing agents in the workplace. Smoking has been docu-Occupational Asthma: Etiologies and Risk Factors
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mented as a significant risk factor for the development of sensi-
tization to a number of occupational agents, such as animal al-
lergens (e.g., laboratory animals, snow crab, prawn, salmon) 
and some LMW agents (e.g., platinum salts, acid anhydrides, 
reactive dyes).
60 However, only a few studies have provided di-
rect evidence that cigarette smoking can increase the risk of 
clinical allergy or OA.
61-65
Exposure to endotoxin, which are components of the outer 
membrane of gram-negative bacteria, occurs in many occupa-
tional settings.
66 There is accumulating evidence that endotoxin 
may affect allergic sensitization to allergens, in addition to in-
ducing asthma-like symptoms and airway neutrophilic inflam-
mation. However, the effects of co-exposure to endotoxin and 
allergens remain uncertain. Endotoxin may either enhance or 
inhibit the allergic process, depending on the timing and dose 
of exposure, as well as the individual genetic background. Pa-
checo et al.
67 showed that the ability to respond to airborne en-
dotoxin through the Toll-like receptor 4 (TLR4) in conjunction 
with an allergen could affect the risk for sensitization to labora-
tory animals. In a survey of laboratory workers, they found that 
the TLR4/8551 G variant, which is less responsive to endotoxin, 
was significantly associated with atopy and sensitization to lab-
oratory animals.
INDIVIDUAL SUSCEPTIBILITY
The observation that only a few workers typically develop OA 
despite similar workplace exposures strongly suggests that un-
derlying differences in individual susceptibility exist. Host fac-
tors that have been incriminated in the development of OA in-
clude atopy, genetic factors, rhinitis, pre-existing non-specific 
airway hyperresponsiveness, and gender.
Atopy
Atopy, which is defined as an increased propensity to produce 
an IgE antibody response to low-dose environmental aeroaller-
gens, can be established by assessing the presence of IgE anti-
bodies against common inhalant allergens. Atopy has been 
consistently documented as a major risk factor for the develop-
ment of IgE-mediated sensitization and OA in response to HMW 
agents that induce the production of specific IgE antibodies.
68,69 
This association remains controversial for some LMW agents, 
such as acid anhydrides
70,71 and platinum salts
72,73. Nevertheless, 
the identification of atopy is not regarded as a reliable marker 
for excluding potentially susceptible workers from exposed jobs 
because it is a highly prevalent trait in the general population, 
and thus yields only a weak positive predictive value for sensiti-
zation to LMW agents and OA.
69 Interestingly, studies suggest 
that atopy could be a stronger risk factor for laboratory animal 
sensitization among workers with low levels of exposure.
47,74 
Furthermore, pre-exposure sensitization to common allergens 
that are structurally related to workplace allergens, such as pets 
in laboratory animal workers, could be a stronger predictor of 
OA than atopy.
75,76 In a 2-year prospective cohort study of work-
ers beginning laboratory animal exposure, the combination of 
atopy and a total IgE level greater than 100 IU/mL was the best 
predictor for the development of laboratory animal allergies.
77 
Using these criteria may make it possible to reduce occupation-
al sensitization by approximately 50% with less than 10% false-
positive predictions. Interestingly, this cohort study found that 
baseline assessments of nasal inflammation parameters or cy-
tokine production profiles did not predict the development of 
specific sensitization.
77
Genetic factors
With current advances in human genetics, research has been 
directed towards investigating the genetic basis of individual 
susceptibility to OA development. Several studies have docu-
mented significant associations between OA due to various 
LMW and HMW occupational allergens (e.g., isocyanates, red 
cedar, acid anhydrides, platinum salts, natural rubber latex, 
laboratory animals) and HLA class II molecules, which are in-
volved in the presentation of processed antigens to T-lympho-
cytes (Table 2).
46,78-86 Specific HLA DR, HLA-DQ, and HLA-DP 
alleles were found to confer either susceptibility or protection 
against OA; however, these findings have not always been repli-
cated in other studies.
87-89
Possible role of genes associated with TH2-cell differentiation 
in the development of OA was suggested in one study that as-
sessed the allelic variants of TH2-related cytokines, IL-4 recep-
tor α chain (IL4RA) and IL-13, and one CD14 (C159T) gene 
polymorphism in isocyanate-induced OA.
90 The IL-4RA (I50V) 
II genotype alone and in combination with IL-13 (R110Q) RR, 
and the CD14 (C159T) genotypes were significantly associated 
with OA caused by hexamethylene diisocyanate. Pacheco et 
al.
67 evaluated whether allelic variants of TLR4, which is the 
predominant endotoxin-specific cell-surface receptor, could 
modulate allergic responses to laboratory animals. The TLR4/ 
8551 G variant, which is less responsive to endotoxin, was sig-
nificantly associated with an increased risk of sensitization to 
laboratory animals and other inhalant allergens.
67 An investiga-
tion of isocyanate-induced innate immune responses found 
that subjects who lacked the major (type 1) human chitinase 
showed decreased serum concentrations of chitinase 3-like-1. 
In contrast, individuals possessing at least one functional chi-
tinase-1 allele did not show this decrease.
91 With respect to neu-
rogenic inflammation, a Korean study found no association be-
tween genetic polymorphisms of the neurokinin 2 receptor 
(NK2R G231E, NK2R R375H) and isocyanate-induced OA. 
However, subjects with the GG genotype of NK2R G231E showed 
higher serum vascular endothelial growth factor (VEGF) levels 
than those with the GA or AA genotype, which may contribute 
to perpetuating airway inflammation.
92
Genes involved in protection against oxidative stress, such as Vandenplas
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glutathione-S-transferase (GSTP1 and GSTM1) and N-acetyl-
transferase (NAT), have been explored in isocyanate-induced 
OA.
93-96 The GSTM1 null genotype was associated with an in-
creased risk of isocyanate-induced OA,
93 while the GSTP1*Val/
Table 2. Genes involved in susceptibility to occupational asthma
Agent No. of subjects with OA Gene Strength of association* Reference
Isocyanates (TDI) 28 SIC+ HLA-DQB1*0503 RR 9.8 78
HLA-DQB1*0201/0301 RR = 9,5 RR 9.5 78
HLA-DQB1*0501 RR 0.1 78
HLA-DQA1*0101 and/or *0102 RR 0.1 78
Isocyanates (TDI) 30 SIC+ HLA-DQB1*0503 RR 2.9 79
HLA-DQB1*0501 RR 0.04 79
Isocyanates (TDI) 67 SIC+ HLA-DQB1*0503 ND 80
HLA-DQA1*0104 ND 80
HLA-DQB1*0501 ND 80
HLA-DQA1*0101 ND 80
Isocyanate (TDI) 84 SIC++ HLA DRB1*1501- DQB1*0602-DPB1*0501 OR 4.4 (1.5-13.1) 86
Anhydride acids 30 IgE+ HLA-DR3 OR 6.0 81
Trimellitic anhydride  11 IgE+ HLA-DR3 OR 16.0 81
Anhydride acids 52 IgE+ HLA-DQ5 OR 4.3 (1.7-11.0) 82
HLA-DQB1*0501 OR 3.0 (1.2-7.4) 82
HLA-DR1 OR 3.0 (1.2-11.0) 82
Platinum salts 44 SPT+ HLA-DR3 OR 2.3 (1.0-5.6) 46
HLA-DR6 OR 0.4 (0.2-0.8) 46
Red cedar 56 SIC+ HLA-DQB1*0302 OR 4.9 (1.3-18.6) 83
HLA-DQB1*0603 OR 2.9 (1.0-8.2) 83
HLA-DQB1*0501 OR 0.3 (0.1-0.8) 83
HLA-DRB1*0401-DQB1*0302 OR 10.3 83
HLA-DRB1*0101-DQB1*0501 OR 0.3 83
Latex (hevein) 189 IgE+ HLA-DQB1*0302 ND 84
HLA-DRB1*04 ND 84
Rat (urinary allergen) 109 IgE/SPT+ HLA-DR 1*07 OR 1.8 (1.1-2.9) 85
HLA-DR 1*03 OR 0.5 (0.3-1.0) 85
Isocyanates (HDI) 62 SIC+ IL-4RA (I50V) OR 3.3 (1.3- 8.1) 90
IL-4RA (I50V) II + IL-13 (R110Q) RR OR 4.1 (1.3-12.7) 90
IL4RA (I50V) II + CD14 (C159T) CT OR 5.2 (1.8-14.9) 90
Laboratory animals 64 SPT/IgE+ Toll-like receptor 4/8551 G variant OR 2.5 (1.5-5.5) 67
Isocyanates (various) 109 SIC/PEF+ GSTM1 null genotype OR 1.9 (1,0-3.5) 93
GSTP1 Val/Val Absent 93
Isocyanates (various) 109 SIC/PEF+ NAT1 (slow acetylor) OR 2.5 (1.3-4.9) 94
GSTM1 nul + NAT1 OR 4.5 (1.7-11.6) 94
GSTM1 nul + NAT2 OR 3.1 (1.1-8.8) 94
Isocyanates (TDI) NAT1 (slow acetylor) OR 7.8 (1.2-51.6) 94
Isocyanates (TDI) 56 SIC+ GSTP1 Val/Val OR 0.2 (0.1-1.1) 95
Isocyanates (various) 47 compensated 1-AT heterozygocity ND 96
Slow acetylor phenotype ND 96
Isocyanates (TDI) 84 SIC+ CTNNA3 SNPs ORs 1.2 to 4.9 97
*The strength of association is expressed by the odds ratio (OR) or relative risk (RR) of OA, with 95% confidence interval in parentheses.
CTNNA3, catenin alpha 3; GSTM, glutathione-S-transferase; HDI, hexamethylene diisocyanate; IgE, presence of specific IgE antibodies; NAT, N-acetyltransferase; 
ND, OR or RR not detailed; NK2R, neurokinin 2 receptor; OA, occupational asthma; PEF, positive peak expiratory flow monitoring; SIC, positive specific inhalation 
challenge; SNP, single nucleotide polymorphism; SPT, positive skin-prick tests; TDI, toluene diisocyanate.Occupational Asthma: Etiologies and Risk Factors
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Val allele conferred protection against the development of OA. 
This protective effect increased with the duration of toluene di-
isocyanate (TDI) exposure.
95 Slow N-acetylator phenotypes were 
found to be at a higher risk for diisocyanate-induced asthma.
94,96
A recent genome-wide association screening among Korean 
workers with OA caused by toluene diisocyanate found that 
several single-nucleotide polymorphisms of catenin alpha 3 
(CTNNA3, coding for alpha T-catenin) and catenin alpha 1 
(CTNNA1, encoding alpha E-catenin) were significantly associ-
ated with OA.
97 Additionally, two genetic polymorphisms of 
CTNNA3 (rs10762058 and rs7088181) were significantly associ-
ated with a higher level of non-specific bronchial hyperrespon-
siveness. An additional polymorphism (rs1786929) was associ-
ated with higher levels of serum-specific IgG against cytokera-
tin 19. Alpha-catenin is a key molecule in the E-cadherin-medi-
ated cell-cell adhesion complex. Further functional studies are 
needed to clarify the exact mechanisms by which CTNNA3 and 
CTNNA1 gene polymorphisms contribute to the development 
of isocyanate-induced OA.
6
Overall, the currently available information indicates that ge-
netic testing is limited for both diagnostic and preventive pur-
poses.
98 It is unknown why one gene may represent a risk factor 
in some populations, but not in others. As an example, the 
HLADQB1*0501 allele is associated with an increased suscepti-
bility for developing specific IgE antibodies against acid anhy-
drides,
82 while the same allele is protective for diisocyanate- and 
plicatic acid-associated OA.
80,83 There is also convincing evidence 
that a wide variety of environmental factors can interact with 
genetic determinants to affect disease susceptibility. These ob-
servations highlight the importance of measuring environmen-
tal exposure in genetic studies of OA. Such environmental fac-
tors include viral infections, diet, exposure to endotoxin, tobac-
co smoke, and irritants, as well as the pattern and timing of ex-
posure to sensitizers in the workplace. For example, a gene-en-
vironment interaction has been demonstrated for sensitization 
to platinum salts.
46 In platinum refinery workers, the relative 
risk of sensitization associated with the HLA-DR3 phenotype 
was more apparent at lower levels of exposure. This finding in-
dicates that the role of genetic susceptibility is likely to increase 
in workplace environments where exposure to sensitizers has 
been minimized.
Non-specific bronchial hyperresponsiveness
In recent years, prospective cohort studies of subjects enter-
ing a workplace with exposure to occupational sensitizers have 
provided formal evidence that baseline bronchial hyperrespon-
siveness and a physician-based diagnosis of asthma are associ-
ated with an increased risk of OA.
76,99
Rhinitis
Population-based and cohort studies provide compelling evi-
dence that rhinitis (allergic and non-allergic) is a risk factor for 
the development of non-occupational asthma.
100-102 Clinical 
studies have shown that the majority of workers with OA also 
suffer from occupational rhinitis. Of these patients, work-relat-
ed rhinitis symptoms frequently precede the onset of OA, espe-
cially when HMW agents are involved.
103 Epidemiological evi-
dence shows that work-related rhinitis is associated with an in-
creased risk for the subsequent development of asthma
104 and 
OA
49,105, and should be considered as an early marker of OA.
106 
However, the proportion of subjects with work-related rhinitis 
who will go on to develop OA remains uncertain. Among ap-
prentices in animal health technology, the predictive value of 
work-related nasal symptoms on the subsequent development 
of probable OA was only 11.4% over a 44-month follow-up peri-
od.
49 Prospective cohort studies of apprentices have also shown 
that the presence of rhinitis prior to work exposure is an inde-
pendent risk factor for IgE sensitization to HMW occupational 
allergens.
99,107
Gender
Disparities in the incidence of OA among men and women 
have usually been ascribed to gender-related differences in job 
distribution. For example, in surveys of workers exposed to snow 
crab allergens, the prevalence of probable OA in women was 
markedly higher than in men. However, it could not be exclud-
ed that this difference was a result of the over representation of 
women in job categories with high exposure.
65,108
CONCLUSIONS
Identifying the intrinsic characteristics of OA-causing agents 
that determine their sensitizing potential is important for pre-
venting the introduction of hazardous substances in the work-
place. A dose-response relationship between exposure levels 
and the development of immunological sensitization and OA 
has now been convincingly established for the most frequent 
agents that cause OA. As a result, preventive measures aimed at 
reducing workplace exposure to sensitizing agents should be 
the most effective approach for reducing the burden of OA. 
However, there is some suggestion that the exposure-response 
relationship may bell-shaped rather than linear for some occu-
pational agents (e.g., laboratory animals, wheat flour), suggest-
ing a protective effect of high-level exposures. Several studies 
indicate that exposure to cigarette smoke can increase the risk 
of IgE-mediated sensitization to some HMW and LMW agents; 
however, the evidence supporting an association between 
smoking and the development of clinical OA remains very weak. 
The role of other environmental co-factors, such as endotoxins 
and chemical pollutants, should be further investigated.
Atopy has been consistently demonstrated as an important 
individual risk factor for the development of IgE sensitization 
and OA, but only for HMW agents. Identifying sub populations 
at higher risk within the atopic group would increase the feasi-Vandenplas
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bility of pre-employment screening and counseling. Prospec-
tive cohort studies of individuals entering a workplace with ex-
posure to occupational sensitizing agents have shown that the 
presence of rhinitis and non-specific bronchial hyperespon-
siveness at baseline are associated with an increased risk of IgE 
sensitization and OA. Associations between genetic markers 
and OA have usually been modest, but there is increasing evi-
dence that gene-environment interactions can influence these 
exposure-response relationships. Characterizing the complex 
interactions between environmental factors and individual sus-
ceptibility is a crucial step in identifying the factors that deter-
mine the development of OA, and in implementing cost-effec-
tive prevention strategies.
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